464 filings
Page 19 of 24
6-K
bi7i07wz4vwjchq0qx
1 Nov 17
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer)i
12:00am
6-K
bwehnclta4l
31 Oct 17
Current report (foreign)
12:00am
6-K
9v6gzl0hsmiyvn7pfb0s
27 Oct 17
Chi-Med Announces the Full Exercise of Underwriters' Over-allotment Option
12:00am
6-K
d3zhsg1lsj44 305
26 Oct 17
Chi-Med Announces Pricing of U.S. Public Offering of ADSs Raising US$262 Million on Nasdaq Global Select Market
12:00am
424B5
djvw4smk
26 Oct 17
Prospectus supplement for primary offering
12:00am
6-K
o87gmrw 0a90qxod
25 Oct 17
Chi-Med Announces Proposed Offering of ADSs
12:00am
424B5
adp5c bwpkhv0o9g9z9l
24 Oct 17
Prospectus supplement for primary offering
12:00am
6-K
ad1uq
19 Oct 17
Current report (foreign)
12:00am
6-K
vtk5r9d5cap3n7 jky
17 Oct 17
Current report (foreign)
12:00am
6-K
6gd3 pqwmkahs
16 Oct 17
Chi-Med Reports Preliminary Phase II data on Fruquintinib Combination in First-Line Lung Cancer
12:00am
6-K
xugf 5o7d19qpiayu
12 Oct 17
Current report (foreign)
12:00am
6-K
tlb2b7qd
29 Sep 17
Current report (foreign)
12:00am
6-K
9ec85
31 Aug 17
Current report (foreign)
12:00am
6-K
d7mp6j
29 Aug 17
Current report (foreign)
12:00am
6-K
o15gsgq dakrz
22 Aug 17
Current report (foreign)
12:00am
6-K
qmjw39hc h1
18 Aug 17
Current report (foreign)
12:00am
6-K
o4gc7t29 hpc3yd4xdg
15 Aug 17
Current report (foreign)
12:00am
6-K
a3wb 4qis
10 Aug 17
Current report (foreign)
12:00am
6-K
iawq kay64
7 Aug 17
Current report (foreign)
12:00am
6-K
skfzc2
31 Jul 17
Chi-Med Reports 2017 Interim Results and Updates Shareholders on Key Clinical Programs
12:00am